Faheem Hasnain's Insider Trades & SAST Disclosures
Faheem Hasnain's most recent trade in Kura Oncology Inc was a trade of 22,682 Common Stock done at an average price of $8 . Disclosure was reported to the exchange on March 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Faheem Hasnain.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kura Oncology Inc | Faheem Hasnain | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 21 Mar 2025 | 22,682 | 23,983 (0%) | 0% | 8 | 181,456 | Common Stock |
| Kura Oncology Inc | Faheem Hasnain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 21 Mar 2025 | 22,682 | 46,665 (0%) | 0% | 6.3 | 143,350 | Common Stock |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,540,000 | 1,540,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.67 per share. | 21 Jun 2024 | 372,000 | 5,408,073 (8%) | 0% | 0.7 | 250,282 | Common Stock |
| Kura Oncology Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Gossamer Bio Inc | Hasnain Faheem | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.16 per share. | 27 Mar 2024 | 23,172 | 120,293 (0%) | 0% | 1.2 | 26,773 | Common Stock |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 1,312,500 | 1,312,500 | - | - | Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | Faheem Hasnain | Director | Purchase of securities on an exchange or from another person at price $ 27.80 per share. | 11 Aug 2023 | 10,791 | 10,791 (0%) | 0% | 27.8 | 299,990 | Common Stock |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 1.82 per share. | 24 Jul 2023 | 540,176 | 5,036,073 (8%) | 0% | 1.8 | 983,120 | Common Stock |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 135,044 | 135,044 | - | - | Common Stock Purchase Warrants | |
| Kura Oncology Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 26,000 | 26,000 | - | - | Option to purchase common stock | |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 544,500 | 544,500 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 20 Mar 2023 | 440,500 | 4,495,897 (7%) | 0% | 1.1 | 503,580 | Common Stock |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 20 Mar 2023 | 269,389 | 4,055,397 (6%) | 0% | 1.2 | 322,324 | Common Stock |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 20 Mar 2023 | 168,683 | 3,786,008 (6%) | 0% | 1.0 | 174,486 | Common Stock |
| Mirati Therapeutics Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 10,716 | 10,716 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 6,333 | 15,050 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 7.21 per share. | 15 Jul 2022 | 138,696 | 3,617,325 (5%) | 0% | 7.2 | 999,998 | Common Stock |
| Kura Oncology Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 8.91 per share. | 23 Mar 2022 | 19,035 | 143,465 (0%) | 0% | 8.9 | 169,697 | Common Stock |
| Mirati Therapeutics Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 5,243 | 5,243 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,619 | 8,717 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) | |
| Kura Oncology Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 325,000 | 325,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 162,500 | 162,500 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 3,064 | 3,064 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,098 | 5,098 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Faheem Hasnain | Director | Purchase of securities on an exchange or from another person at price $ 10.36 per share. | 14 Oct 2020 | 96,520 | 3,478,629 (5%) | 0% | 10.4 | 999,995 | Common Stock |
| Kura Oncology Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Gossamer Bio Inc | Faheem Hasnain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 47,000 | 47,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges